^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
BXQ-350
i
Other names: Saposin C–dioleoylphosphatidylserine complexes, BXQ-350, BXQ 350, SapC-DOPS, SapC, SapC-DOPS nanovesicles
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Bexion, Cincinnati Children's Hospital Medical Center
Drug class:
Apoptosis stimulant, S1P receptor inhibitor
Related drugs:
